β-Catenin overexpression in dupuytren's disease is unrelated to disease recurrence

Clinical Orthopaedics and Related Research

Volumn 467, Issue 3, 2009, Pages 838-845

  Degreef, Ilse ^a   De Smet, Luc ^a   Sciot, Raf ^a   Cassiman, Jean Jacques ^a   Tejpar, Sabine ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; WNT PROTEIN; WNT5A PROTEIN; ACTIN; CTNNB1 PROTEIN, HUMAN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DUPUYTREN CONTRACTURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; MYOFIBROBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; CELL PROLIFERATION; CHEMISTRY; FIBROBLAST; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; UPREGULATION;

ACTINS; ADULT; AGED; BETA CATENIN; CELL PROLIFERATION; DUPUYTREN'S CONTRACTURE; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TREATMENT OUTCOME; UP-REGULATION; WNT PROTEINS; YOUNG ADULT;

EID: 60549083111     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0590-z     Document Type: Article

References (26)

1. Y Abe T Rokkaku S Ofuchi S Tokunaga K Takahashi H Moriya 2004 An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease J Hand Surg Br. 29 427 430 (Pubitemid 39186085)
2. J Aitchison 1982 The statistical analysis of compositional data J R Stat Soc B. 44 139 177
3. MM Al-Qattan 2006 Factors in the pathogenesis of Dupuytren's contracture J Hand Surg Am. 31 1527 1534 (Pubitemid 44692396)
4. E Bowley DB O'Gorman BS Gan 2007 Beta-catenin signalling in fibroproliferative disease J Surg Res. 138 141 150
5. NW Bulstrode B Jemec PJ Smith 2005 The complications of Dupuytren's contracture surgery J Hand Surg Am. 30 1021 1025 (Pubitemid 41337932)
6. A Cordova M Tripoli B Corradino P Napoli F Moschella 2005 Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives J Hand Surg Br. 30 557 562 (Pubitemid 41614183)
7. JJ Dias J Braybrooke 2006 Dupuytren's contracture: an audit of the outcomes of surgery J Hand Surg Br. 31 514 521 (Pubitemid 44321360)
8. G Gabbiani 2003 The myofibroblast in wound healing and fibrocontractive diseases J Pathol. 200 500 503 (Pubitemid 36818250)
9. S Hindocha S John JK Stanley SJ Watson A Bayat 2006 The heritability of Dupuytren's disease: familial aggregation and its clinical significance J Hand Surg Am. 31 204 210 (Pubitemid 43227269)
10. S Hindocha JK Stanley S Watson A Bayat 2006 Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence J Hand Surg Am. 31 1626 1634 (Pubitemid 44834570)
11. JC Howard VM Varallo DC Ross JH Roth KJ Faber B Alman BS Gan 2003 Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro BMC Musculoskelet Disord. 4 16
12. H Iwasaki H Müller HJ Stutte U Brennscheidt 1984 Palmar fibrosis (Dupuytren's contracture) Virchows Arch A Pathol Anat Histopathol. 405 41 53
13. R Kalluri M Zeisberg 2006 Fibroblasts in cancer Nat Rev Cancer. 6 392 401
14. V Luck 1959 Dupuytren's contracture J Bone Joint Surg Am. 41 635 664
15. McFarlane RM, McGrouther DA, Flint MH. Dupuytren's Disease. New York, NY: Churchill Livingstone; 1990.
16. P Meister JM Gokel K Remberger 1979 Palmar fibrosis-"Dupuytren's contracture": a comparison of light electron and immunofluorescence microscopic findings Pathol Res Pract. 164 402 412 (Pubitemid 10231003)
17. E Montgomery AL Folpe 2005 The diagnostic value of beta-catenin immunohistochemistry Adv Anat Pathol. 12 350 356
18. E Montgomery JH Lee SC Abraham TT Wu 2001 Superficial fibromatosis are genetically different from deep fibromatoses Mod Pathol. 14 695 701 (Pubitemid 32667214)
19. DB O'Gorman Y Wu S Seney RD Zhu BS Gan 2006 Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's disease J Negat Results Biomed. 5 13
20. JJ Rombouts H Noël Y Legrain E Munting 1989 Prediction of recurrence in the treatment of Dupuytren's disease: evaluation of a histologic classification J Hand Surg Am. 14 644 652 (Pubitemid 19189532)
21. S Tejpar F Nollet C Li JS Wunder G Michils P dal Cin E Van Cutsem B Bapat F van Roy JJ Cassiman BA Alman 1999 Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor) Oncogene. 18 6615 6620
22. R Teo F Mohrlen G Plickert WA Muller U Frank 2006 An evolutionary conserved role of Wnt signaling in stem cell fate decision Dev Biol. 289 91 99 (Pubitemid 41805094)
23. J Tomasek GM Rayan 1995 Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts J Hand Surg Am. 20 450 455
24. JJ Tomasek G Gabbiani B Hinz C Chaponnier RA Brown 2002 Myofibroblasts and mechano-regulation of connective tissue remodelling Nat Rev Mol Cell Biol. 3 349 363 (Pubitemid 34619269)
25. VM Varallo BS Gan S Seney DC Ross JH Roth RS Richerds RM McFarlane B Alman JC Howard 2003 Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro Oncogene. 22 3680 3684 (Pubitemid 36760730)
26. S Wilbrand C Flodmark A Ekborm B Gerdin 2003 Activation markers of connective tissue in Dupuytren's contracture: relation to postoperative outcome Scand J Plast Reconstr Surg Hand Surg. 37 283 292 (Pubitemid 37352420)